Phase II study of oral masitinib mesilate in imatinib-naive patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST).

Abstract

International audienc

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Last time updated on 19/05/2022